Showing results (511-520 of 676) with videos related to
Sort By:
Pageof 68
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Germline SDHA mutations in children and adults with cancerMarianne Dubard Gault, Diana Mandelker, Deborah DeLair, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Therapeutic Implications of Germline Testing in Patients With Advanced CancersZsofia K Stadler, Anna Maio, Debyani Chakravarty, et al.Human Genetics|January 25, 2012
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang, Hemang Parikh, Jinping Jia, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.Nature Genetics|October 9, 2007
Network modeling links breast cancer susceptibility and centrosome dysfunctionMiguel Angel Pujana, Jing-Dong J Han, Lea M Starita, et al.Cancer Discovery|December 24, 2021
Cancer-Causative Mutations Occurring in Early EmbryogenesisFresia Pareja, Ryan N Ptashkin, David N Brown, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMary B Daly, Tuya Pal, Michael P Berry, et al.JCO Precision Oncology|July 12, 2021
Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient PopulationErin E Salo-Mullen, Anna Maio, Semanti Mukherjee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2019
Cancer Susceptibility Mutations in Patients With Urothelial MalignanciesMaria I Carlo, Vignesh Ravichandran, Preethi Srinavasan, et al.Breast Cancer Research and Treatment|September 27, 2012
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriersKristen N Stevens, Xianshu Wang, Zachary Fredericksen, et al.Pageof 68